Is VSee Health, Inc. (VSEEW) overvalued at rev $10.4M?

VSee Health, Inc. (VSEEW) rev $10.4M.

Is this a short call on VSEEW?

No. A rich cached multiple is not a short thesis.

VSee Health, Inc. (VSEEW) common stock listed on NASDAQ.

This page asks whether VSee Health, Inc. (VSEEW) looks expensive on cached numbers — not a short thesis.

Latest reported VSEEW revenue for 2024-12-31 was $10.4M. Net income was -$57.7M. VSEEW currently screens at market cap $0.

VSEEW currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next VSEEW 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the VSEEW stock page for the full model, not this heading.

Not investment advice.